All patients underwent a complete ophthalmic examination, including measurements of best corrected visual acuity (BCVA); refraction tests; slit-lamp biomicroscopy; Goldmann applanation tonometry; gonioscopy; dilated stereoscopic examination of the optic disc; measurements of corneal curvature (KR-1800; Topcon, Tokyo, Japan), central corneal thickness (CCT) (Orbscan II; Bausch & Lomb Surgical, Rochester, NY, USA), and axial length (IOL Master version 5; Carl Zeiss Meditec, Dublin, CA, USA); stereo disc photography (EOS D60 digital camera; Canon, Utsunomiya-shi, Tochigi ken, Japan); spectral-domain (SD) optical coherence tomography (OCT) (Spectralis; Heidelberg Engineering, Heidelberg, Germany); and standard automated perimetry (Humphrey Field Analyzer II 750 and 24-2 Swedish interactive threshold algorithm; Carl Zeiss Meditec).
NTG was diagnosed according to the following criteria: intraocular pressure (IOP) ≤21 mm Hg on multiple measurements on the same day or over a few days before starting IOP-lowering medication, an open angle on gonioscopy, glaucomatous optic nerve damage (e.g., diffuse or localized rim thinning, notching, or disc hemorrhage), and associated VF defects without ocular disease or conditions that may cause VF abnormalities. A glaucomatous VF change was defined as the fulfillment of two or more of the following criteria: (1) outside normal limits on the glaucoma Hemifield test; (2) three abnormal points with <5% probability of being normal, including one with a probability <1%, by pattern deviation; or (3) a pattern standard deviation of probability <5%. These VF defects were confirmed on two consecutive reliable tests (fixation loss rate ≤20%, false-positive and false-negative error rates ≤25%).
32
We included patients with genetic (
OPA1 mutations) or clinical diagnosis of ADOA. Family history was considered for both criteria. Clinical diagnosis of ADOA was based on a history of gradual, bilateral vision loss; dyschromatopsia; a central, cecocentral, or paracentral scotoma; optic disc pallor; and bilaterally symmetric RNFL loss involving the temporal sector.
33 The parents, and when necessary the grandparents, of each patient underwent a complete ophthalmologic examination that included BCVA evaluation, fundus photography, VF examination, and a color test. Any patients with the possibility of optic atrophy of other causes, such as acute visual loss, pain, previous febrile event, drug history, and disc hemorrhage or edema, were excluded.
Healthy control individuals included subjects with an IOP ≤21 mm Hg with no history of increased IOP, absence of a glaucomatous disc, a circumpapillary RNFL thickness within the normal range (as measured by SD-OCT), and a normal VF. The absence of a glaucomatous disc was defined as an intact appearing neuroretinal rim without disc hemorrhages, notches, rim thinning, adjacent RNFL defect, or localized pallor. Two independent glaucoma specialists (G.N.K and J.-A.K) evaluated the optic disc. Disagreements between the observers were resolved by a third adjudicator (T.-W.K.). The normal range of RNFL thickness was defined as a circumpapillary RNFL thickness within the 95th percentile of the normative database, whereas VF was considered normal when there were no glaucomatous VF or neurologic defects.
34,35
Eyes were excluded if they had a BCVA worse than 20/40, a spherical equivalent less than –6.0 diopter (D) or greater than +3.0 D, a cylinder correction of less than –3.0 D or greater than +3.0 D, a tilted disc (i.e., a tilt ratio >1.3 between the longest and shortest diameters of the optic disc),
36,37 or a torted disc (i.e., a torsion angle deviation of the long axis of the optic disc from the vertical meridian of >15°)
37,38; a history of intraocular surgery, except for uneventful cataract surgery; or the presence of a retinal or neurologic disease other than ADOA that may affect VF. Eyes were also excluded if a good-quality image (i.e., quality score >15) could not be obtained in more than five sections; if this quality score was not attained, the image-acquisition process automatically stopped, or images of the respective sections were not obtained. LC depth (LCD) and LC curvature index (LCCI) were measured only on acceptable scans with good-quality images that allowed clear delineation of the anterior border of the LC within the Bruch's membrane opening (BMO).